azelaic acid
NDC 68462-626, azelaic acid, gel, from Glenmark Pharmaceuticals Inc., USA.
- Product NDC
- 68462-626
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204637
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZELAIC ACID.15 g/g
Pharmacologic classes
Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-626-52 | 68462062652 | 1 TUBE in 1 CARTON (68462-626-52) / 50 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0b5ab22e-c78a-4429-9a76-a4ba2d11fcdeNADAC price for package 68462062652
GET /v1/drugs/nadac/68462062652
Use it
Look up 68462-626 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.